Haresh Kirpalani1, Edward F Bell1, Susan R Hintz1, Sylvia Tan1, Barbara Schmidt1, Aasma S Chaudhary1, Karen J Johnson1, Margaret M Crawford1, Jamie E Newman1, Betty R Vohr1, Waldemar A Carlo1, Carl T D'Angio1, Kathleen A Kennedy1, Robin K Ohls1, Brenda B Poindexter1, Kurt Schibler1, Robin K Whyte1, John A Widness1, John A F Zupancic1, Myra H Wyckoff1, William E Truog1, Michele C Walsh1, Valerie Y Chock1, Abbot R Laptook1, Gregory M Sokol1, Bradley A Yoder1, Ravi M Patel1, C Michael Cotten1, Melissa F Carmen1, Uday Devaskar1, Sanjay Chawla1, Ruth Seabrook1, Rosemary D Higgins1, Abhik Das1. 1. From the Department of Pediatrics, University of Pennsylvania, and Children's Hospital of Philadelphia, Philadelphia (H.K., B.S., A.S.C.); the Department of Pediatrics, University of Iowa, Iowa City (E.F.B., K.J.J., J.A.W.); the Department of Pediatrics, Division of Neonatal and Developmental Medicine, Stanford University School of Medicine and Lucile Packard Children's Hospital, Palo Alto (S.R.H., V.Y.C.), and the Department of Pediatrics, University of California, Los Angeles, Los Angeles (U.D.) - both in California; the Biostatistics and Epidemiology Division, RTI International, Research Triangle Park (S.T., M.M.C.), and the Department of Pediatrics, Duke University School of Medicine, Durham (C.M.C.) - both in North Carolina; the Biostatistics and Epidemiology Division, RTI International, Rockville (J.E.N., A.D.), and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda (R.D.H.) - both in Maryland; the Department of Pediatrics, Women and Infants Hospital, Brown University, Providence, RI (B.R.V., A.R.L.); the Division of Neonatology, University of Alabama at Birmingham, Birmingham (W.A.C.); the University of Rochester School of Medicine and Dentistry, Rochester, NY (C.T.D., M.F.C.); the Department of Pediatrics, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston (K.A.K.), and the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas (M.H.W.); the University of New Mexico Health Sciences Center, Albuquerque (R.K.O.); the Department of Pediatrics, Division of Neonatology, University of Utah School of Medicine, Salt Lake City (R.K.O., B.A.Y.); the Department of Pediatrics, Indiana University School of Medicine, Indianapolis (B.B.P., G.M.S.); Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati (B.B.P., K.S.), the Department of Pediatrics, Rainbow Babies and Children's Hospital, Case Western Reserve University, Cleveland (M.C.W.), and Nationwide Children's Hospital and the Department of Pediatrics, Ohio State University College of Medicine, Columbus (R.S.); the Department of Pediatrics, Dalhousie University, Halifax, NS, Canada (R.K.W.); the Department of Neonatology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston (J.A.F.Z.); the Department of Pediatrics, Children's Mercy Hospital, Kansas City, MO (W.E.T.); Emory University School of Medicine, Department of Pediatrics, Children's Healthcare of Atlanta, Atlanta (R.M.P.); the Department of Pediatrics, Wayne State University, Detroit (S.C.); and the College of Health and Human Services, George Mason University, Fairfax, VA (R.D.H.).
Abstract
BACKGROUND: Limited data suggest that higher hemoglobin thresholds for red-cell transfusions may reduce the risk of cognitive delay among extremely-low-birth-weight infants with anemia. METHODS: We performed an open, multicenter trial in which infants with a birth weight of 1000 g or less and a gestational age between 22 weeks 0 days and 28 weeks 6 days were randomly assigned within 48 hours after delivery to receive red-cell transfusions at higher or lower hemoglobin thresholds until 36 weeks of postmenstrual age or discharge, whichever occurred first. The primary outcome was a composite of death or neurodevelopmental impairment (cognitive delay, cerebral palsy, or hearing or vision loss) at 22 to 26 months of age, corrected for prematurity. RESULTS: A total of 1824 infants (mean birth weight, 756 g; mean gestational age, 25.9 weeks) underwent randomization. There was a between-group difference of 1.9 g per deciliter (19 g per liter) in the pretransfusion mean hemoglobin levels throughout the treatment period. Primary outcome data were available for 1692 infants (92.8%). Of 845 infants in the higher-threshold group, 423 (50.1%) died or survived with neurodevelopmental impairment, as compared with 422 of 847 infants (49.8%) in the lower-threshold group (relative risk adjusted for birth-weight stratum and center, 1.00; 95% confidence interval [CI], 0.92 to 1.10; P = 0.93). At 2 years, the higher- and lower-threshold groups had similar incidences of death (16.2% and 15.0%, respectively) and neurodevelopmental impairment (39.6% and 40.3%, respectively). At discharge from the hospital, the incidences of survival without severe complications were 28.5% and 30.9%, respectively. Serious adverse events occurred in 22.7% and 21.7%, respectively. CONCLUSIONS: In extremely-low-birth-weight infants, a higher hemoglobin threshold for red-cell transfusion did not improve survival without neurodevelopmental impairment at 22 to 26 months of age, corrected for prematurity. (Funded by the National Heart, Lung, and Blood Institute and others; TOP ClinicalTrials.gov number, NCT01702805.).
BACKGROUND: Limited data suggest that higher hemoglobin thresholds for red-cell transfusions may reduce the risk of cognitive delay among extremely-low-birth-weight infants with anemia. METHODS: We performed an open, multicenter trial in which infants with a birth weight of 1000 g or less and a gestational age between 22 weeks 0 days and 28 weeks 6 days were randomly assigned within 48 hours after delivery to receive red-cell transfusions at higher or lower hemoglobin thresholds until 36 weeks of postmenstrual age or discharge, whichever occurred first. The primary outcome was a composite of death or neurodevelopmental impairment (cognitive delay, cerebral palsy, or hearing or vision loss) at 22 to 26 months of age, corrected for prematurity. RESULTS: A total of 1824 infants (mean birth weight, 756 g; mean gestational age, 25.9 weeks) underwent randomization. There was a between-group difference of 1.9 g per deciliter (19 g per liter) in the pretransfusion mean hemoglobin levels throughout the treatment period. Primary outcome data were available for 1692 infants (92.8%). Of 845 infants in the higher-threshold group, 423 (50.1%) died or survived with neurodevelopmental impairment, as compared with 422 of 847 infants (49.8%) in the lower-threshold group (relative risk adjusted for birth-weight stratum and center, 1.00; 95% confidence interval [CI], 0.92 to 1.10; P = 0.93). At 2 years, the higher- and lower-threshold groups had similar incidences of death (16.2% and 15.0%, respectively) and neurodevelopmental impairment (39.6% and 40.3%, respectively). At discharge from the hospital, the incidences of survival without severe complications were 28.5% and 30.9%, respectively. Serious adverse events occurred in 22.7% and 21.7%, respectively. CONCLUSIONS: In extremely-low-birth-weight infants, a higher hemoglobin threshold for red-cell transfusion did not improve survival without neurodevelopmental impairment at 22 to 26 months of age, corrected for prematurity. (Funded by the National Heart, Lung, and Blood Institute and others; TOP ClinicalTrials.gov number, NCT01702805.).
Authors: Ursula Guillén; James J Cummings; Edward F Bell; Shigerharu Hosono; Axel R Frantz; Rolf F Maier; Robin K Whyte; Elaine Boyle; Max Vento; John A Widness; Haresh Kirpalani Journal: Semin Perinatol Date: 2012-08 Impact factor: 3.300
Authors: Amélia Miyashiro Nunes dos Santos; Ruth Guinsburg; Maria Fernanda Branco de Almeida; Renato S Procianoy; Cléa Rodrigues Leone; Sérgio Tadeu Martins Marba; Ligia Maria Suppo de Souza Rugolo; Humberto Holmer Fiori; José Maria de Andrade Lopes; Francisco Eulógio Martinez Journal: J Pediatr Date: 2011-04-13 Impact factor: 4.406
Authors: Edward F Bell; Ronald G Strauss; John A Widness; Larry T Mahoney; Donald M Mock; Victoria J Seward; Gretchen A Cress; Karen J Johnson; Irma J Kromer; M Bridget Zimmerman Journal: Pediatrics Date: 2005-06 Impact factor: 7.124
Authors: Dean Fergusson; Paul C Hébert; Shoo K Lee; C Robin Walker; Keith J Barrington; Lawrence Joseph; Morris A Blajchman; Stan Shapiro Journal: JAMA Date: 2003-04-16 Impact factor: 56.272
Authors: Ravi M Patel; Andrea Knezevic; Neeta Shenvi; Michael Hinkes; Sarah Keene; John D Roback; Kirk A Easley; Cassandra D Josephson Journal: JAMA Date: 2016-03-01 Impact factor: 56.272
Authors: Orlyn C Lavilla; Khyzer B Aziz; Allison C Lure; Daniel Gipson; Diomel de la Cruz; James L Wynn Journal: Am J Respir Crit Care Med Date: 2022-01-01 Impact factor: 21.405
Authors: Edward F Bell; Barbara J Stoll; Nellie I Hansen; Myra H Wyckoff; Michele C Walsh; Pablo J Sánchez; Matthew A Rysavy; Jenna H Gabrio; Stephanie W Archer; Abhik Das; Rosemary D Higgins Journal: Semin Perinatol Date: 2022-06-10 Impact factor: 3.311
Authors: Valerie Y Chock; Emily Smith; Sylvia Tan; M Bethany Ball; Abhik Das; Susan R Hintz; Haresh Kirpalani; Edward F Bell; Lina F Chalak; Waldemar A Carlo; C Michael Cotten; John A Widness; Kathleen A Kennedy; Robin K Ohls; Ruth B Seabrook; Ravi M Patel; Abbot R Laptook; Toni Mancini; Gregory M Sokol; Michele C Walsh; Bradley A Yoder; Brenda B Poindexter; Sanjay Chawla; Carl T D'Angio; Rosemary D Higgins; Krisa P Van Meurs Journal: Pediatr Res Date: 2022-05-05 Impact factor: 3.953
Authors: Minesh Khashu; Christof Dame; Pascal M Lavoie; Isabelle G De Plaen; Parvesh M Garg; Venkatesh Sampath; Atul Malhotra; Michael D Caplan; Praveen Kumar; Pankaj B Agrawal; Giuseppe Buonocore; Robert D Christensen; Akhil Maheshwari Journal: Newborn (Clarksville) Date: 2022-03-31
Authors: Nathan M Money; Alan R Schroeder; Ricardo A Quinonez; Timmy Ho; Jennifer R Marin; Elizabeth R Wolf; Daniel J Morgan; Sanket S Dhruva; Eric R Coon Journal: Pediatrics Date: 2022-02-01 Impact factor: 7.124
Authors: Ravi M Patel; Jeanne E Hendrickson; Marianne E Nellis; Rebecca Birch; Ruchika Goel; Oliver Karam; Matthew S Karafin; Sheila J Hanson; Bruce S Sachais; Ronald George Hauser; Naomi L C Luban; Jerome Gottschall; Cassandra D Josephson; Martha Sola-Visner Journal: J Pediatr Date: 2021-04-07 Impact factor: 6.314